A Multi-Site, Double-Blind, Randomized, Placebo-Controlled, Crossover Study of Pregabalin (Lyrica, PGB) in the Treatment of the Essential Tremor

Kelly L. Sullivan

A Multi-Site, Double-Blind, Randomized, Placebo-Controlled, Crossover Study of Pregabalin (Lyrica, PGB) in the Treatment of the Essential Tremor

Biostatistics, Epidemiology, & Environmental Health Sciences

Research output: Other contribution › Other

Original language	American English
State	Published - 2007

DC Disciplines

Epidemiology
Public Health

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@misc{11e5f62d2eb04b45b41c72d3339e77dd,

title = "A Multi-Site, Double-Blind, Randomized, Placebo-Controlled, Crossover Study of Pregabalin (Lyrica, PGB) in the Treatment of the Essential Tremor",

author = "Sullivan, {Kelly L.}",

note = "Kelly L. Sullivan (Epidemiologist & Project Manager), {"}A Multi-Site, Double-Blind, Randomized, Placebo-Controlled, Crossover Study of Pregabalin (Lyrica, PGB) in the Treatment of the Essential Tremor,{"} Pfizer (Investigator Initiated). (2007-2011).",

year = "2007",

language = "American English",

type = "Other",

}

TY - GEN

T1 - A Multi-Site, Double-Blind, Randomized, Placebo-Controlled, Crossover Study of Pregabalin (Lyrica, PGB) in the Treatment of the Essential Tremor

AU - Sullivan, Kelly L.

N1 - Kelly L. Sullivan (Epidemiologist & Project Manager), "A Multi-Site, Double-Blind, Randomized, Placebo-Controlled, Crossover Study of Pregabalin (Lyrica, PGB) in the Treatment of the Essential Tremor," Pfizer (Investigator Initiated). (2007-2011).

PY - 2007

Y1 - 2007

M3 - Other

ER -